Table 9.
ROC analysis for differentiating grade 1 versus grade 2/3 inflammation, oedema, and prominent muscle hypertrophy versus prominent fibrosis.
| Parameter | Inflammation | Oedema | Prominent muscle hypertrophy versus prominent fibrosis | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AUC | p | Cut-off | Se | Sp | AUC | p | Cut-off | Se | Sp | AUC | p | Cutoff | Se | Sp | |
| Length of involved bowel | 0.7 | 0.036 | 4.5 mm | 88% | 60% | 0.527 | 0.766 | 0.713 | 0.054 | ||||||
| Wall thickness on T2WI | 0.64 | 0.142 | 0.527 | 0.766 | 0.742 | 0.029 | 7.4 mm | 61% | 89% | ||||||
| Wall thickness on T1WI post-contrast | 0.725 | 0.018 | 5.9 mm | 72% | 73% | 0.651 | 0.102 | 0.711 | 0.056 | ||||||
| ADC | 0.728 | 0.029 | 1.11 × 10-3 mm2/s | 70% | 75% | 0.602 | 0.305 | 0.556 | 0.637 | ||||||
| MaRIA score | 0.736 | 0.013 | 26.1 | 96% | 53% | 0.697 | 0.032 | 23.5 | 90% | 50% | 0.71 | 0.058 | |||
| Clermont score | 0.667 | 0.11 | 0.776 | 0.005 | 28.7 | 90% | 63% | 0.727 | 0.054 | ||||||
Significant p-values are bolded.
Se, sensitivity; Sp, specificity; AUC, area under the curve.